Current advancements in tubulin targeting agents for breast cancer: Design strategies, structure-activity relationships, and pharmacological insights.

Breast cancer remains one of the most common causes of cancer mortality worldwide and, despite improvements in early detection and targeted therapies, resistance, recurrence, and metastasis still impair therapeutic success. Microtubule-targeting agen…

Preview only. Read the full abstract at the source